• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动与心力衰竭的相似之处:预防心房颤动的经验教训。

Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.

作者信息

McManus David D, Shaikh Amir Y, Abhishek Fnu, Vasan Ramachandran S

机构信息

Departments of Medicine and Quantitative Health Sciences, University of Massachusetts Medical Center, Worcester, MA 01655, USA.

出版信息

Crit Pathw Cardiol. 2011 Mar;10(1):46-51. doi: 10.1097/HPC.0b013e31820e1a4b.

DOI:10.1097/HPC.0b013e31820e1a4b
PMID:21562376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3220939/
Abstract

Heart failure (HF) and atrial fibrillation (AF) are 2 of the most common cardiovascular diseases encountered in clinical practice, and the prevalence of these diseases continues to grow worldwide with the aging of the global population. While recognizing that AF is a heterogeneous disorder, we submit that the parallels between AF and HF may arise because many cases of AF and HF result from the cumulative exposure of the atria and ventricles to a common set of systemic cardiovascular risk factors. Over time, exposure to risk factors promotes development of atrial and ventricular structural and functional abnormalities through activation of several biologic pathways in concert: upregulation of neurohormonal signaling cascades, release of inflammatory mediators, programmed cell death, and fibrosis. Cardiac structural remodeling occurs in concert with electrophysiologic remodeling, both of which contribute to atrial and ventricular rhythm disturbances, including AF. AF and HF, instead of representing distinct disease processes, often represent different endpoints along a disease continuum. By reviewing some of the mechanistic parallels between AF and HF, we hope to emphasize the connection between established cardiovascular risk factors, cardiac remodeling and AF, with a view to promote strategies for AF prevention.

摘要

心力衰竭(HF)和心房颤动(AF)是临床实践中最常见的两种心血管疾病,随着全球人口老龄化,这些疾病在全球的患病率持续上升。虽然认识到AF是一种异质性疾病,但我们认为AF和HF之间可能存在相似之处,因为许多AF和HF病例是由于心房和心室长期暴露于一组共同的全身性心血管危险因素所致。随着时间的推移,暴露于危险因素会通过协同激活多种生物学途径促进心房和心室结构及功能异常的发展:神经激素信号级联反应上调、炎症介质释放、程序性细胞死亡和纤维化。心脏结构重塑与电生理重塑同时发生,两者均导致心房和心室节律紊乱,包括AF。AF和HF并非代表不同的疾病过程,而往往代表疾病连续体上的不同终点。通过回顾AF和HF之间的一些机制相似之处,我们希望强调既定心血管危险因素、心脏重塑与AF之间的联系,以期促进AF预防策略。

相似文献

1
Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.心房颤动与心力衰竭的相似之处:预防心房颤动的经验教训。
Crit Pathw Cardiol. 2011 Mar;10(1):46-51. doi: 10.1097/HPC.0b013e31820e1a4b.
2
Contribution of fibrosis and the autonomic nervous system to atrial fibrillation electrograms in heart failure.纤维化和自主神经系统对心力衰竭心房颤动电图的贡献。
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):640-9. doi: 10.1161/CIRCEP.111.970095. Epub 2012 Jun 21.
3
Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlap.冠心病、心房颤动或心力衰竭门诊患者的二级预防及结局:关注疾病重叠情况
Open Heart. 2020 Apr 21;7(1):e001165. doi: 10.1136/openhrt-2019-001165. eCollection 2020.
4
A temporal window of vulnerability for development of atrial fibrillation with advancing heart failure.随着心力衰竭的进展,心房颤动的易损期窗口。
Eur J Heart Fail. 2014 Mar;16(3):271-80. doi: 10.1002/ejhf.28. Epub 2014 Jan 9.
5
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.心力衰竭中的心房颤动:流行病学、病理生理学及治疗原理
Am J Cardiol. 2003 Mar 20;91(6A):2D-8D. doi: 10.1016/s0002-9149(02)03373-8.
6
The role of interleukins in pathogenesis and prognosis of atrial fibrillation.白细胞介素在心房颤动发病机制和预后中的作用。
Expert Rev Clin Immunol. 2023 Jun;19(6):585-597. doi: 10.1080/1744666X.2023.2196013. Epub 2023 Mar 31.
7
Left Atrial Remodeling Mechanisms Associated with Atrial Fibrillation.左心房重构与心房颤动的关联机制。
Cardiovasc Eng Technol. 2021 Jun;12(3):361-372. doi: 10.1007/s13239-021-00527-w. Epub 2021 Mar 1.
8
Atrial fibrillation in heart failure: what should we do?心力衰竭中的心房颤动:我们该怎么做?
Eur Heart J. 2015 Dec 7;36(46):3250-7. doi: 10.1093/eurheartj/ehv513. Epub 2015 Sep 28.
9
The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases.心力衰竭与心房颤动的共同特征及相互影响:两种与衰老相关的心脏病的起始、进展及转归
Heart Fail Rev. 2022 May;27(3):837-847. doi: 10.1007/s10741-021-10095-9. Epub 2021 Mar 25.
10
Management strategies in atrial fibrillation in patients with heart failure.心力衰竭合并心房颤动的管理策略。
Cardiol Rev. 2012 Nov-Dec;20(6):288-96. doi: 10.1097/CRD.0b013e31825dcf9b.

引用本文的文献

1
Application value of real-time 3D speckle tracking imaging in left atrial function evaluation of patients with paroxysmal atrial fibrillation.实时三维斑点追踪成像技术在阵发性心房颤动患者左房功能评估中的应用价值。
Medicine (Baltimore). 2024 May 24;103(21):e38206. doi: 10.1097/MD.0000000000038206.
2
The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation-The HARVEST-Malmö study.心肌纤维化生物标志物在合并心房颤动的心力衰竭人群中的影响——哈维斯-马尔默研究
Front Cardiovasc Med. 2022 Oct 19;9:982871. doi: 10.3389/fcvm.2022.982871. eCollection 2022.
3
Electrochemically driven optical and SERS immunosensor for the detection of a therapeutic cardiac drug.用于检测一种治疗性心脏药物的电化学驱动光学和表面增强拉曼散射免疫传感器。
RSC Adv. 2022 Jan 20;12(5):2901-2913. doi: 10.1039/d1ra07680a. eCollection 2022 Jan 18.
4
Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation.可溶性 ST2 在预测心房颤动患者心力衰竭和死亡中的作用。
Clin Cardiol. 2022 Apr;45(4):447-456. doi: 10.1002/clc.23799. Epub 2022 Feb 21.
5
A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation.心脏纤维化和心房颤动潜在分子机制的综述
J Clin Med. 2021 Sep 27;10(19):4430. doi: 10.3390/jcm10194430.
6
High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study.高血浆谷氨酸水平和低谷氨酰胺/谷氨酸比值与心力衰竭风险增加相关,但与心房颤动无关:来自地中海饮食预防研究(PREDIMED)。
J Nutr. 2020 Nov 19;150(11):2882-2889. doi: 10.1093/jn/nxaa273.
7
Regulation of left atrial fibrosis induced by mitral regurgitation by SIRT1.SIRT1 调控二尖瓣反流引起的左心房纤维化。
Sci Rep. 2020 Apr 29;10(1):7278. doi: 10.1038/s41598-020-64308-6.
8
Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.心房颤动与心力衰竭双重流行的治疗考量
J Atr Fibrillation. 2013 Aug 31;6(2):740. doi: 10.4022/jafib.740. eCollection 2013 Aug-Sep.
9
The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.心房颤动与慢性肾脏病的关系:两种流行病的流行病学和病理生理学考量
J Atr Fibrillation. 2012 Jun 15;5(1):442. doi: 10.4022/jafib.442. eCollection 2012 Jun-Jul.
10
No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.心房颤动发作后心力衰竭风险无下降:一项评估总体趋势及按射血分数分层趋势的社区研究。
Heart Rhythm. 2017 Jun;14(6):791-798. doi: 10.1016/j.hrthm.2017.01.031. Epub 2017 Jan 21.

本文引用的文献

1
The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.肾素-血管紧张素系统阻断疗法在预防心房颤动中的作用:一项随机对照试验的荟萃分析。
Clin Pharmacol Ther. 2010 Oct;88(4):521-31. doi: 10.1038/clpt.2010.123. Epub 2010 Sep 1.
2
Non-antiarrhythmic drugs to prevent atrial fibrillation.非抗心律失常药物预防心房颤动。
Am J Cardiovasc Drugs. 2010;10(3):165-73. doi: 10.2165/11537270-000000000-00000.
3
Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT.2009 年欧洲心脏病学会会议上的临床试验最新进展:AAA、RELY、PROTECT、ACTIVE-I、欧洲 CRT 调查、德国 SCD II 登记研究以及 MADIT-CRT。
Eur J Heart Fail. 2009 Dec;11(12):1214-9. doi: 10.1093/eurjhf/hfp162.
4
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.心房颤动与心力衰竭:双重流行疾病的治疗考量
Circulation. 2009 May 12;119(18):2516-25. doi: 10.1161/CIRCULATIONAHA.108.821306.
5
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.心房颤动的预防:美国国立心肺血液研究所研讨会报告
Circulation. 2009 Feb 3;119(4):606-18. doi: 10.1161/CIRCULATIONAHA.108.825380.
6
Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management.
Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):46-56. doi: 10.1038/ncpcardio1414. Epub 2008 Dec 2.
7
Ethical authorship and publishing.道德作者身份与出版
Int J Cardiol. 2009 Jan 9;131(2):149-50. doi: 10.1016/j.ijcard.2008.11.048. Epub 2008 Nov 28.
8
Molecular genetics of atrial fibrillation.心房颤动的分子遗传学
J Am Coll Cardiol. 2008 Jul 22;52(4):241-50. doi: 10.1016/j.jacc.2008.02.072.
9
Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study).左心房容积指数对预测冠心病门诊患者心力衰竭住院率和死亡率的价值以及与左心室射血分数的比较(来自“心灵研究”)
Am J Cardiol. 2008 Jul 1;102(1):70-6. doi: 10.1016/j.amjcard.2008.02.099. Epub 2008 May 9.
10
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.伴有或不伴有ST段抬高的急性冠脉综合征患者发生心房颤动后的短期和长期结局
Heart. 2008 Jul;94(7):867-73. doi: 10.1136/hrt.2007.134486. Epub 2008 Mar 10.